We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

35 hedge funds and large institutions have $9.78M invested in Cocrystal Pharma in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 1.31% → 1.29% (-0.02%)

15% less funds holding

Funds holding: 41 → 35 (-6)

39% less capital invested

Capital invested by funds: $16.1M → $9.78M (-$6.28M)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
35
Holders Change
-6
Holders Change %
-14.63%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
10
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$488K
2
JP Morgan Chase
JP Morgan Chase
New York
+$50.2K
3
UBS Group
UBS Group
Switzerland
+$19.8K
4
LPL Financial
LPL Financial
California
+$18.6K
5
TSS
Two Sigma Securities
New York
+$18.5K

Top Sellers

Rank Fund Capital Flow
1
Mariner
Mariner
Kansas
-$315K
2
Millennium Management
Millennium Management
New York
-$143K
3
Goldman Sachs
Goldman Sachs
New York
-$120K
4
Citadel Advisors
Citadel Advisors
Florida
-$114K
5
Renaissance Technologies
Renaissance Technologies
New York
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$3.73M +$488K +47,726 +11%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.13M -$3.25K -317 -0.1%
Renaissance Technologies
3
Renaissance Technologies
New York
$1.24M -$106K -10,320 -6%
BlackRock
4
BlackRock
New York
$730K +$8.38K +819 +0.9%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$520K – – –
Morgan Stanley
6
Morgan Stanley
New York
$464K – – –
State Street
7
State Street
Massachusetts
$178K – – –
LPL Financial
8
LPL Financial
California
$130K +$18.6K +1,813 +12%
PA
9
Parallel Advisors
California
$119K – – –
Verition Fund Management
10
Verition Fund Management
Connecticut
$104K – – –
Northern Trust
11
Northern Trust
Illinois
$93K – – –
Bank of America
12
Bank of America
North Carolina
$70K +$133 +13 +0.1%
JP Morgan Chase
13
JP Morgan Chase
New York
$39K +$50.2K +4,902 +5,160%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$35K -$3.25K -317 -7%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$29K – – –
TSS
16
Two Sigma Securities
New York
$26K +$18.5K +1,808 +121%
UBS Group
17
UBS Group
Switzerland
$23K +$19.8K +1,939 +194%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$21K – – –
BJL
19
Brighton Jones LLC
Washington
$18K -$6.83K -667 -22%
Commonwealth Equity Services
20
Commonwealth Equity Services
Massachusetts
$17K +$8.53K +833 +60%
RJFSA
21
Raymond James Financial Services Advisors
Florida
$16K – – –
Goldman Sachs
22
Goldman Sachs
New York
$11K -$120K -11,690 -89%
BRWA
23
B. Riley Wealth Advisors
Florida
$9K – – –
Jane Street
24
Jane Street
New York
$9K +$1.77K +173 +19%
Victory Capital Management
25
Victory Capital Management
Texas
$8K -$348 -34 -3%
1
2

COCP Hedge Fund Activity: Q4 2021 in Review

35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q4 2021, worth a combined $9.78M — down 39% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of COCP and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 10 added.

The largest buyer was Sabby Management, adding an estimated $488K. The largest seller was Mariner, exiting entirely with an estimated $315K sold.

  • 35 institutional investors held Cocrystal Pharma (COCP) as of Q4 2021, down from 41 in Q3 2021.
  • Funds reported $9.78M of Cocrystal Pharma stock for Q4 2021, down 39% quarter-over-quarter.
  • 2 funds opened new Cocrystal Pharma positions in Q4 2021 and 8 closed out, a net change of -6 holders.
  • The largest Cocrystal Pharma buyer in Q4 2021 was Sabby Management, an estimated $488K added.
  • The largest Cocrystal Pharma seller in Q4 2021 was Mariner, an estimated $315K sold.

Based on aggregated 13F filings for Q4 2021.